People: Avacta Group PLC (AVTG.L)

AVTG.L on London Stock Exchange

0.93GBp
11:19am EDT
Price Change (% chg)

-0.02p (-2.12%)
Prev Close
0.94p
Open
0.94p
Day's High
0.93p
Day's Low
0.90p
Volume
3,291,365
Avg. Vol
2,436,133
52-wk High
1.60p
52-wk Low
0.66p

Search Stocks

Summary

Name Age Since Current Position

Gwyn Humphreys

 66 2005 Independent Non-Executive Chairman of the Board

Alastair Smith

 Chief Executive Officer, Executive Director

Timothy Sykes

 2007 Chief Financial Officer, Company Secretary, Executive Director

Alan Aubrey

 50 Independent Non-Executive Director

Anthony Robards

 Independent Non-Executive Director

Simone Elviss

 IR Contact Officer
» Insider Trading

Biographies

Name Description

Gwyn Humphreys

 Dr. Gwyn O. Humphreys is Independent Non-Executive Chairman of the Board of Avacta Group Plc. He has experience of technology transfer and early-stage technology companies. Originally a biochemist/molecular biologist, Gwyn spent ten years in academic research, followed by ten years at Celltech Limited where, for three years, he was responsible for creating and managing a joint venture company (Apcel) with Air Products. In 1995 Gwyn was a founder and Managing Director of Bradford Particle Design plc, a pharmaceutical technology company which grew rapidly and profitably and was sold in 2001 to Nektar Therapeutics Inc for $200M. Gwyn is also non-executive Director of a Canadian respiratory drug delivery company, SolAeroMed Inc, and since May 2012 has been interim Chief Executive Officer of Evocutis plc having previously been non-executive Director.

Alastair Smith

 Professor Alastair Smith, Ph.D., is Chief Executive Officer, Executive Director of Avacta Group Plc. He has a degree and PhD in Physics from Manchester University and, after working in the US for a period, took up a position at Leeds University in 1995. Alastair rapidly grew one of the research groups in Europe developing new biophysical technologies and applying them to solve problems in the Life Sciences. At the age of 38 he was awarded a Chair of Molecular Biophysics for this work and was founding Director of the Institute of Molecular Biophysics at Leeds University. He co-founded Avacta in January 2004 and left his academic position to concentrate full time on his role as Chief Executive Officer of Avacta in 2007.

Timothy Sykes

 Mr. Timothy J. Sykes is Chief Financial Officer, Company Secretary, Executive Director of Avacta Group Plc. He is a qualified Chartered Accountant and a Director of Penta Financial Direction Limited, his own business advisory practice, which specialises in providing services to small businesses. He is Chief Financial Officer of PROACTIS Holdings PLC. Prior to this, Tim was an Associate Director within KPMG’s Transaction Services Group.

Alan Aubrey

 Mr. Alan John Aubrey is Independent Non-Executive Director of Avacta Group Plc. He is the Chief Executive Officer of IP Group plc, a company that invests in and builds technology businesses based on intellectual property originating from Universities and other research intensive institutions. He is also a Non-Executive in several listed technology companies. From 1995-2002, Alan was a corporate finance partner at KPMG. He is a fellow of the Institute of Chartered Accountants of England and Wales.

Anthony Robards

 Professor Anthony Robards, OBE, is Independent Non-Executive Director of Avacta Group Plc. After first and higher degrees in Biology at University College London, Tony came to York in 1966 to pursue an academic career in biological research. In 1996 he was appointed Pro-Vice-Chancellor for External Relations at the University of York, a post he held for eight years. In 2001, Tony was appointed the first HSBC Chair of Innovation at the University of York. Tony’s commitment to creating links between the University and external organisations has led to a wide range of business activities and he has been President of the York and North Yorkshire Chamber of Commerce, Joint Executive of Science City York, Chair of York Science Park Limited and Venturefest York Limited, as well as a Non-executive Chairman of YorkTest Group Limited. He is now Non-executive Director of York Science Park plc, Pro-Cure Therapeutics Limited, York Science and Innovation Grand Tour Limited and is Chairman of the Board of Trustees of Yorkshire Cancer Research.

Simone Elviss

Basic Compensation

Name Fiscal Year Total

Gwyn Humphreys

 52,000

Alastair Smith

 248,000

Timothy Sykes

 137,000

Alan Aubrey

 --

Anthony Robards

 --

Simone Elviss

 --
As Of 30 Jul 2012

Options Compensation

Name Options Value

Gwyn Humphreys

 0 0

Alastair Smith

 0 0

Timothy Sykes

 0 0

Alan Aubrey

 0 0

Anthony Robards

 0 0

Simone Elviss

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks